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1. Introduction
Necrotising enterocolitis (NEC) is a progressive disease of the neonatal intestine beginning
in the distal ileum and proximal colon and characterised by inflammatory necrosis [1,2]. It
typically affects low birth-weight, preterm infants who account for the majority (70–90%) of
cases [3–5]. Since the 1960s, advances in medical care have raised the survival rate for preterm
infants with increasingly shortened gestation periods, resulting in a concomitant surge in
NEC cases. The overall incidence of NEC is generally accepted as ranging from <1% to 5%
of neonatal intensive care unit (NICU) admissions, or up to 5 cases per 1,000 live births [4–
6]. There is an inverse relationship between NEC and birth-weight, so that very low birth-
weight infants (VLBW; <1500 g) carry the greatest burden of disease [4,5,7]. Caplan report‐
ed NEC rates for VLBW infants vary greatly across countries, ranging from 1.5% in Japan to
28% in Hong Kong, with racial  disparity apparent in VLBW black infants who have an
increased risk and greater associated mortality [5,8]. Despite advances in neonatal care, the
overall mortality remains high at around 20–30% [3,8-10]. An estimated 20-40% of infants
with NEC require surgery, which has a case fatality rate of up to 50%, the smallest, least
mature infants having the worst prognosis [5]. Most cases of NEC are sporadic with no clear
seasonal distribution, but outbreaks have been documented [5]. Treatment of NEC is mainly
supportive with the administration of broad-spectrum antibiotics while surgery is indicat‐
ed for intestinal perforation or removal of necrotic bowel segments. NEC complications and
sequelae include serious neurodevelopmental delay, poor growth, intestinal obstruction due
to scarring, short bowel syndrome, and liver failure due to prolonged hyperalimentation [6,
9]. The annual financial cost of NEC is considerable and in the USA has been estimated at
$500 million to $1 billion [9].
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1.1. Clinical classification
The classification system of Bell has historically proved important in defining three main
stages: suspected, definite and advanced NEC [11]. Modifications to Bell’s criteria have
provided a more detailed system of clinical staging as shown in Table 1 [12,13]. However,
Gordon et al and others have challenged the belief that NEC is a single entity, preferring to
view it as an umbrella term for a number of separate diseases with some common features
[13,14]. Although relatively uncommon, conditions, which mimic neonatal NEC, such as focal
bowel perforation, intussusception, ecchymotic colitis, appendicitis and shigellosis, have been
reported and may complicate the clinical diagnosis [14-18].
Stage
(NEC) Systemic signs Radiographic findings Intestinal signs
Stage I
(suspected)
Temperature instability,
apnoea, bradycardia
Normal or intestinal
dilation; mild ileus
Gastric residuals, occult blood, mild
abdominal distension
Stage II A
(definite)
Temperature instability,
apnoea, bradycardia
Intestinal dilation, ileus,
focal pneumatosis
Blood in stools, prominent abdominal
distension, absent bowel sounds
Stage II B
(definite)
As above plus mild
metabolic acidosis and
thrombocytopenia
As II A plus portal vein
gas, ascites
Abdominal wall oedema with palpable
loops and tenderness
Stage III A
(advanced)
As stage II B plus mixed
acidosis, oligouria,
hypotension, coagulopathy
As II B plus worsening
ascites
Worsening wall oedema, erythema and
induration
Stage III B
(advanced)
As II A, shock, deterioration
in vital signs
As II B plus
pneumoperitoneum Perforated bowel
Table 1. Modified Bell’s staging for necrotising enterocolitis (adapted from Kliegman RM et al and Gordon et al
[12,13])
1.2. Risk factors
So far, four major risk factors for NEC have been defined with prematurity being the most
consistent. At 36 weeks gestation there is a sharp decrease in the incidence of NEC, supporting
the concept that gut maturation provides significant protection against development of the
disease [4]. Nevertheless, NEC in term and high birth-weight infants is not unknown, although
the risk factors appear to be somewhat different [4,6,13]. The introduction of enteral feeds,
particularly formula milk, and subsequent colonisation of the neonatal intestinal tract with
bacteria are believed to be significant risk factors in the development of NEC [4,6,19]. Not only
does formula milk lack the gastrointestinal protective, anti-inflammatory and maturation
factors present in breast milk, it can be a source of Cronobacter sakazakii, a neonatal pathogen
implicated in some cases of NEC [19]. Early research concentrated on the role of hypoxia and
ischaemia, with the idea that the subsequent mucosal injury due to lack of oxygenation initiates
NEC through promotion of bacterial translocation and the inflammatory cascade [1]. Many
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animal models of NEC have subsequently relied on reproducing this type of damage [5,20,21].
Kosloske et al suggested the ‘dive reflex’, whereby blood flow is diverted away from the GI
tract to vital organs, as one mechanism of intestinal injury but current opinion, based on
analyses of risk factors over several decades, favours a secondary role for hypoxia-ischaemia
[5]. Nevertheless, the fact that NEC most commonly occurs in the distal ileum and proximal
colon, the watershed areas of the mesenteric arteries, suggests inadequate or disordered blood
circulation constitutes a risk factor in some circumstances [1,22]. Prenatal circulatory events,
umbilical and aortic catheterisation with dispersion of small emboli and congenital heart
disease have been linked to NEC, but occur in a minority of cases [2,4]. Preterm neonates are
more susceptible to hypoxia and intestinal ischaemia than term neonates because of poor
vascular resistance [1,4,22]. However, there is a stronger association between NEC, prematur‐
ity, enteral feeding and the presence of bacteria in the GI tract than hypoxia-ischaemia [1,5,22].
Overall, ischaemia/reperfusion injury seems to be more relevant to the development of NEC
in term infants and those preterm infants with spontaneous intestinal perforations [23]. Yet
hypoxia may exert a subtle effect by sensitising the intestinal epithelium to bacterial products
and this is discussed in more detail in section 4.1 [24].
Recent evidence has linked blood transfusions with subsequent NEC in extremely premature
infant [25–30]. The terms TANEC (Transfusion Associated NEC) and TRAGI (Transfusion-
Related Acute Gut Injury) have been coined, referring to this association [25,31]. A recent meta-
analysis examining evidence for the association concludes that recent transfusion is associated
with NEC, and that transfusion-associated NEC has a higher risk of mortality than NEC which
was not preceded by transfusion [25]. The reason for the association, and whether it is causal
has not been elucidated. Prior to concern about TRAGI, Doppler studies have shown a decrease
in neonatal superior mesenteric blood flow during and after blood transfusion [32]. The reason
for this is not clear, but blood transfusion appears to have wide-ranging effects on haemody‐
namics, possibly as a result of changes in the microcirculation. Digestion of food requires a
major increase in gut blood supply and it has been suggested that limiting or ceasing milk
feeds before, during and after a blood transfusion in susceptible babies may decrease the risk
of TRAGI. This has not been subjected to any systematic study and therefore remains specu‐
lative. The need for a co-ordinated approach to investigate the association between blood
transfusion and NEC has been highlighted by Blau et al and there is an online world registry
for TRAGI (www.tragiregistry.com) [31]. Any trial of an intervention for TRAGI prophylaxis
would need large numbers, requiring a multicentre approach.
There are other characteristics of the preterm infant favouring the development of NEC. The
combination of poor gut motility and under-production of mucous decreases clearance and
increases exposure of the epithelium to potentially harmful components of the luminal
contents [1,5,19]. Moreover, induction of foetal hypoxia can further reduce postnatal intestinal
motility [1]. The lumen contents of preterm infants may be more acidic, due to inadequate
digestion/absorption of nutrients and bacterial fermentation of undigested milk, or more toxic,
as formula feeding elicits toxic bile acids [1]. Bacterial overgrowth, as indicated by a positive
hydrogen breath test, is considered to be a further consequence of delayed transit time and
may promote NEC through increasing bacterial translocation from the intestinal lumen into
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the tissues or through exposure to high concentrations of bacterial antigens [33,34]. More
recently, it has been proposed that genetic polymorphisms in the genes encoding the inter‐
leukin (IL) 4 binding receptor alpha chain and the chemokine IL-8 may also be a risk factor for
NEC [35]. Intrauterine infection is another risk factor for NEC; the microorganisms implicated
and proposed causality are discussed in section 2.3.
In the normal course of events, acquisition of the enteric microbiota begins during the birth
process through the ingestion of bacteria of maternal origin. Breastfeeding, handling by the
mother and exposure to environmental bacteria create further opportunities for gaining new
species [6]. Colonisation takes place in the first few days of life and is influenced by a multitude
of factors such as mode of delivery, type of feeding (breast milk or formula), gestation age,
hospitalisation, the surrounding environs, maternal infection and antibiotic therapy, with
mode of delivery and type of feeding considered the most significant [36]. Whereas breast fed
infants are regarded as having an enteric microbiota rich in bifidobacteria, a more diverse
microbiota, including potentially pathogenic groups such as Clostridium and Enterobacteria‐
ceae, has been traditionally associated with formula fed infants. However, modern infant
formulas more closely represent breast milk, shifting the gut microbiota towards beneficial
species such as lactobacilli [19,36]. Breast-fed infants are less likely to develop NEC as breast
milk contains many protective bioactives [1]. The initial neonatal microbiota consists of
facultative anaerobic bacteria such as Enterobacteriaceae, enterococci, streptococci and staphy‐
lococci, which are present within days of birth [33]. These bacteria consume oxygen providing
the reducing conditions required for the growth of obligate anaerobes, typically bifidobacteria,
clostridia and Bacteroides, appearing one to two weeks later [33,36]. It is well established that
the intestinal microbiota has a profound effect on gut health, influencing physiology and
metabolism, as well as maturing the infant immune system and protecting against pathogens
[19,33]. However, in the preterm infant, the normal succession of bacterial colonisers may be
interrupted by the administration of broad-spectrum antibiotics, gut immaturity, acquisition
of nosocomial bacteria in the NICU and placement of orogastric or nasogastric feeding tubes,
resulting in a more restricted enteric microbiota with delayed colonisation with bifidobacteria
and without the individual differences seen in the healthy, term neonate [6,33,37]. The
relationship between delayed succession, bacterial overgrowth and NEC is discussed in more
detail elsewhere in this chapter.
2. The role of microbes in NEC
The belief bacteria are crucial for the development of NEC stems from a number of clinical and
experimental findings. In two studies totalling over 100 infants, Sántulli et al and Schullinger
et al were the first to credibly establish bacterial colonisation of the neonatal intestine was a
requirement for this disease [38,39]. NEC does not usually occur immediately post-partum but
some days later, when feeding has usually commenced and there is ample opportunity for
substantial intestinal colonisation. Early-onset NEC occurs in the first week and it is more often
seen in term or near term infants with risk factors such as cardiac disease or severe placental
insufficiency, whereas in infants of lower gestational age/birth-weight, NEC is delayed until
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13-32 days [40,41]. The reason for this difference is not entirely clear, but it may relate to a
difference in pathophysiology, with bowel ischaemia being the predominant factor in early-
onset NEC and cytokine priming being the predominant factor in late-onset NEC. The case for
bacterial colonisation is further strengthened by the absence of NEC in ischaemic, ileal
segments of germ-free rats and in infants who are stillborn [42,43].
Regardless of the initiating factors, pathological changes certainly involve bacteria as the
intramural gas produced in pneumatosis intestinalis contains hydrogen of bacterial origin [44].
Demonstration of bacteria and bacterial DNA in the intestinal wall of resected segments from
NEC infants supports this finding [45,46]. Epidemiological studies also indicate NEC has an
infectious origin as it may occur in clusters of related cases which are amenable to infection
control measures [47]. Moreover, prevention of NEC has been achieved through the adminis‐
tration of enteral antibiotics [48]. Bacteraemia and endotoxinaemia are frequent complications
of NEC but are more likely to be sequelae rather than the actual cause [49,50]. Historically,
there have been many proposals put forward regarding the aetiology of NEC (reviewed by
Obladen [14]) but two main theories have emerged concerning the infectious component:
Specific pathogen theory
This theory relies on the existence of a hitherto undiscovered, single bacterial pathogen causing
intestinal infection in susceptible infants.
Abnormal colonisation theory
Even in health, many members of the enteric microbiota can be considered to have pathogenic
potential. When the balance between pathogenic and commensal species shifts in favour of
the former, a chain of events is triggered in susceptible infants resulting in NEC.
2.1. Microbes implicated in the aetiology of NEC
Enteric anaerobes
Among the enteric anaerobes, Clostridium species are notorious for their proteolytic, saccha‐
rolytic, toxin and gas producing activities, making them ideal candidate microorganisms for
the specific pathogen theory. Pederson et al emphasised the similarities between neonatal NEC
and gas gangrene of the bowel, suggesting that ischaemic lesions were ideal sites for clostridial
invasion, the anaerobic conditions of the bowel favouring conversion of the spores to toxin-
producing bacteria [51]. Studying the histology of resected intestinal segments from NEC
infants led these researchers to conclude Clostridium perfringens (C. welchii) type A was the most
likely cause. Some early experiments on germ-free rats showed injection of C. perfringens spores
into the intestinal wall induced pneumatosis intestinalis, whereas a variety of other intestinal
bacteria did not [52]. Parallels were drawn with pigbel, an acute necrotising enterocolitis
common in older children and adults in Papua New Guinea, caused by type C porcine
Clostridium perfringens [52,53]. These and other findings focused attention on the clostridia for
many years. Several investigations indicated C. perfringens was more commonly isolated from
NEC infants prior to, and at the time of presentation compared to control infants [54–56].
However, negative findings include the long-term study of Dittmar et al where C. perfrin‐
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gens was present in only nine of 41 cases of NEC, with organisms mostly recovered from the
peritoneal cavity rather than stool, while Gupta et al did not detect clostridia in any of 23 NEC
cases [57,58]. Although it’s unlikely C. perfringens is the specific pathogen in NEC, intestinal
colonisation with this organism was observed to be associated with a more severe form of the
disease, a finding supported by Kosloske and Ulrich, and Bjornvad et al in an animal model
[45,57,59]. As the oxygen tension of healthy tissue is likely to inhibit growth of clostridia, pre-
existing tissue necrosis may be exigent. The hypothesis that clostridial alpha-toxin plays a
major role in NEC has never been proven [57].
C. difficile produces two large molecular weight toxins known to cause antibiotic-associated
colitis. Somewhat surprisingly, colonisation with this microbe seems not to be a risk factor for
NEC, probably because the neonatal bowel is tolerant to C. difficile toxins [55,60,61]. C.
butyricum has been advocated as a cause of NEC but Blakey et al found it was not more common
in patients compared to controls [55]. A novel Clostridium, designated C. ‘neonatale’ was
purported to be the cause of an outbreak of NEC in a Canadian hospital but has not been
reported since [62].
Other intestinal anaerobic genera have not been fully investigated, probably due to the
difficulty of culturing under strict anaerobic conditions. Despite the prevailing view that non-
sporing anaerobes are frequently absent in the intestinal tract of preterm infants, a DNA-based
study indicated Bacteroides were abundant, and a review of anaerobic bacteraemia in a NICU
carried out by Noel et al indicated anaerobic bacteraemia was frequently linked to NEC [63,64].
It is likely that further culture-independent studies will be able to better define the contribution
these bacteria make to the pathogenesis of NEC.
Staphylococci
Coagulase negative staphylococci (CoNS) are commonly found in the stools of NEC infants
and have been associated with significant disease [65,66]. Hoy et al noted their presence in
duodenal aspirates of VLBW infants [10]. The role of staphylococcal delta(δ)-toxin was
examined by Scheifele et al and Scheifele and Bjornson, who believed that toxin positive CoNS
were enteropathic [67,68]. δ-toxin, a secreted protein with a detergent-like action, caused
significant bowel necrosis in infant rats and was cytotoxic for fibroblasts in vitro. Moreover, it
could be detected in the stools of infants colonised with δ-toxin producing CoNS [67,68].
We investigated 25 CoNS isolates from the stools of six NEC and six control infants in Dunedin
Hospital NICU. A diagnosis of NEC was made on the basis of clinical indications and pneu‐
matosis intestinalis or peritonitis on X-ray as described previously [69]. CoNS were identified
using API ID-32 STAPH strips (bioMérieux). PCR primers for the δ-toxin gene were based on
sequence data published by Tegmark et al and PCR conditions were as described by McIntosh
[70,71]. Cell-free culture supernatants of the CoNS isolates and a δ-toxin producing S. aureus
control were tested for cell damage (cytopathic effect; CPE) against the small and large
intestinal tissue culture cell lines, Caco2 and HT29 [70]. The results, summarised in Table 2,
suggest that the δ-toxin gene was frequently present in CoNS isolated from the infants (23 of
25 isolates) but that insufficient toxin was produced to cause a CPE in either of the cell lines
tested compared to the Staphylococcus aureus control, which induced cell death. Reduced
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potency of exotoxins is a common feature of CoNS such as S. epidermidis, and probably explains
their low virulence compared to S. aureus [72]. However, this may not always be the case. We
found the culture supernatant of a single S. epidermidis isolate among 29 CoNS isolated from
the skin and nares of University of Otago undergraduate students which could induce a
cytopathic effect in the intestinal cell lines (Table 2). The toxic strain was positive for the δ-
toxin gene by PCR and Southern hybridisation, although we lacked the specific antibody
required to ultimately prove the cytopathic activity was δ-toxin mediated. The δ-toxin theory
has been largely dismissed, but our research suggests there may be occasional strains of S.
epidermidis producing significant amounts of toxin. The findings of Scheifele et al may reflect
the dominance of such strains at a particular time in their NICU. There is one instance of a
small outbreak of NEC and bacteraemia associated with a δ-toxin-producing methicillin
resistant S. aureus, supporting the hypothesis that this toxin may contribute to the pathology
of NEC providing it is produced in sufficient quantities in vivo [73].
Rejection of the δ-toxin theory does not preclude a role for CoNS per se, which are known to
express a number of other virulence factors [74]. In addition, preterm infants exhibit deficien‐
cies in immune responses to CoNS, suggesting they may cause more aggressive infections in
this group compared to term neonates [75]. Large, relatively stable reservoirs of CoNS have
been identified in the faces, ear region, axillae and nares of preterm infants, with smaller, less
stable populations elsewhere on the skin, indicating the widespread presence of this group of
bacteria and their easy access to the GI tract [76].
Subjects NEC infants (n=6) non-NEC infants (n=6) Students (n=19)
CoNS isolates tested n=15 n=10 n=29
Staphylococcus: †δ + ‡CPE δ + CPE δ + CPE
S. epidermidis 11 0 6 0 15 1
Other 3 0 3 0 13 0
†δ + indicates presence of delta-toxin gene
‡CPE: cytopathic effect of CoNS culture supernatant on intestinal cell lines HT29 and Caco2.
Table 2. Presence of delta-toxin gene and cytopathic effect of coagulase-negative staphylococci colonies cultured
from the stools of infants with and without necrotising enterocolitis and the skin/nares of university students.
Enterobacteriaceae
The Enterobacteriaceae family includes both classical enteric pathogens, such as Salmonella,
Shigella and diarrhoeagenic Escherichia coli, and commensals inhabiting the large intestine. It
is the commensals that are common in the enteric microbiota of neonates, including those who
develop NEC. Despite their commensal status, these enterobacteria often possess specific
virulence factors and are a common cause of extra-intestinal infection. There are early reports
of a particular association between Klebsiella, E. coli and NEC, with isolation of the same
organisms from the blood in some cases [77–79]. A number of subsequent studies have
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demonstrated their predominance in the faecal microbiota and duodenal aspirates of NEC
infants [3,10,58,80]. Enterobacter cloacae, Klebsiella spp. and E. coli appear to be the most common
NEC-associated bacteria overall [3,69,77–79,81]. With the exception of Cronobacter (Enterobact‐
er) sakazakii, which appears to be a special case, many other investigations have not shown a
link between particular species or strains and NEC.
Characteristics of E. cloacae relevant to the pathogenesis of NEC include resistance to comple‐
ment-mediated killing (serum resistance), adherence to and invasion of eukaryotic cells in vitro
and chelation of iron [69,82]. In Klebsiella species, bacterial capsules are responsible for
resistance to complement-mediated killing and phagocytosis by polymorphonuclear granu‐
locytes as well as inhibition of macrophages. Differences in virulence between strains are
believed to depend on the presence of repetitive sugar sequences in the capsule, which mediate
lectin-dependent phagocytosis [83]. Adherence to eukaryotic cells and iron chelation are other
virulence factors reported in Klebsiella [69,83]. More recently, a cytotoxin has been detected in
K. oxytoca causing antibiotic-associated haemorrhagic colitis [84]. E. coli is notable for its ability
to acquire virulence factors which endow it with diarrhoeagenic capacity, but such virulence
factors are only occasionally present in isolates from the stools and duodenal aspirates of NEC
infants [3,10,58]. E. coli cultured from the blood and stools of NEC cases have been shown to
pass through epithelial cell monolayers in vitro and highly adherent strains induced NEC-like
injury in a weanling rabbit ileal loop model. However, E. coli from NEC infants were not shown
to be more virulent than those from matched control infants [85,86]. Commensal Enterobacter‐
iaceae are not exclusively found in NEC infants, nor are they present in all cases, so they cannot
be regarded as the specific pathogen for NEC [3,69,79]. Nevertheless, their frequent occurrence
and possession of relevant virulence factors does allow for them to have an important role.
Like many other investigators, we have been unable to show Enterobacteriaceae cultured from
the stools of NEC infants harbour more virulence factors than those without, although the
uncertainty regarding the pathogenesis of NEC presents a barrier to discerning essential
pathogenic characteristics.
Cronobacter spp. are recognised opportunist pathogens of neonates causing bacteraemia and
meningitis as well as being NEC associated. Epidemiological studies have shown powdered
infant formula to be the source of the microorganism in many cases although other sources,
such as the maternal birth canal are suspected [87,88]. A typical outbreak of C. sakazakii
associated NEC is described by van Acker et al [89]. Neonates who developed NEC over a two-
month period were fed milk formula contaminated with C. sakazakii, with a cessation of cases
when the formula was removed. C. sakazakii is the most common Cronobacter species in neonatal
infection but does not fulfil the criteria for the single, specific agent of NEC as it is infrequently
isolated [87]. The high mortality rate in C. sakazakii infection has stimulated research into the
virulence of this species, and this is discussed in a later section.
Classical enteric pathogens
Reports citing classical enteric pathogens such as salmonellae and shigellae as causes of NEC
or NEC-like conditions are rare [18,90]. Enteric viruses such as norovirus, rotavirus, torovirus,
and astrovirus are more frequently implicated. Some investigators consider norovirus to be
an emerging pathogen in the NICU, with NEC representing a severe presentation of infection
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[91,92]. Human astrovirus was reported by Bagci et al to be the cause of NEC in a subgroup
of infants and torovirus was found to be more common in NEC compared to control infants
by Lodha et al [93,94]. Rotavirus has been demonstrated in the stools of neonates from day 4
of life and its presence is considered a risk factor for NEC [95]. Echovirus type 22, renamed
human parechovirus, is also considered to be an enteric pathogen, although causality has not
been fully established [96]. Birenbaum et al detected this virus in an outbreak of diarrhoeal
illness in a NICU with some patients exhibiting the clinical signs and symptoms of NEC [97].
Rousset et al noted the presence of coronavirus-like particles in gut tissue samples from NEC
infants and proposed that secondary proliferation of anaerobic bacteria occurred in the gut
wall following viral damage of the intestinal epithelium [98].
The advent of molecular techniques has facilitated the detection of viruses and it is likely that
future investigations will better define the viruses associated with NEC. However, claims that
viruses are the cause of NEC are not substantiated by the pathology, which strongly supports
a role for bacteria. It is more likely that viruses predispose infants to NEC through damage to
the epithelium, aiding translocation of the bacteria into the intestinal submucosa. In this regard,
both rotavirus and norovirus infections have been shown to lead to epithelial barrier dysfunc‐
tion through a reduction in sealing tight junctional proteins and an increase in epithelial cell
apoptosis [99-101]. Which viruses are involved and how frequently they occur remains open
to question as most studies failed to simultaneously investigate the bacteria present, which
may have been the invasive organisms causing NEC. It is unlikely that viruses or classical
enteric pathogens are the specific pathogens in NEC as they are not universally present. For
example, in a comprehensive study of 27 NEC infants, Ullrich et al found common bacterial,
viral and parasitic gastrointestinal pathogens were absent in all cases [102]. Gordon et al have
proposed viral NEC is a separate disease with a lower mortality rate [13]. However, the
difficulty of clinically distinguishing between viral and bacterial NEC, coupled with the
likelihood that secondary bacterial invasion occurs, renders this argument more academic than
practical.
2.2. Diversity and numbers
It is clear many of the bacteria forming part of the enteric microbiota have pathogenic potential
and it has been suggested that when the balance between pathogenic and commensal species
shifts in favour of the former, a chain of events is triggered in susceptible infants leading to
NEC. A number of studies have sought to investigate this abnormal colonisation theory by
identifying and quantifying enteric bacteria at the time of NEC presentation and comparing
the results with a control group of healthy infants. However, there is evidence the intestinal
ecosystem is altered by inflammation while the microbiota is restored after the inflammatory
signal is dissipated [103]. This may be described as a ‘chicken and egg’ situation; it is unclear
whether changes in the microbiota of NEC infants cause the disease or are a result of the
inflammation. Of particular value are prospective investigations, as they have the potential to
elucidate the microbiota associated with the initiation of NEC
The early, prospective study of Hoy et al was restricted to culturable bacteria, but nevertheless
demonstrated considerable quantitative changes in the faecal microbiota preceding both
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confirmed and suspected episodes of NEC, with a decline in some species up to 72 hours before
clinical onset and the emergence of others, particularly Enterobactericeae [80]. Most human
colonic bacteria are not amenable to culture, so molecular studies constitute a more promising
line of enquiry. Techniques are mainly based on the gene encoding the 16S subunit of bacterial
ribosomal RNA. This gene has hypervariable regions which are genus- and sometimes species-
specific. Sequencing certain hypervariable regions of the 16S rRNA gene and comparing with
sequences of known bacteria deposited in databases is now a common and accepted method
of identification. Variations of this technique include the use of species-specific fluorescent 16S
rDNA probes which bind to bacteria in situ (fluorescent in situ hybridisation; FISH), and 16S
polymerase chain reaction denaturing gel gradient electrophoresis (16S PCR-DGGE) which
separates 16S rDNA fragments from the different species present in a mixed community of
bacteria.
A recent study encompassing both culture and molecular techniques has strengthened the
argument that Enterobacteriaceae and staphylococci are important NEC-associated bacteria. In
a prospective study, Stewart et al found differences in the gut microbiota of preterm infants
who developed NEC or positive blood cultures. Certain Gram-positive genera, Enterococcus
and Streptococcus were more frequent in health while Enterobacter and Staphylococcus were
associated with disease. Moreover, these changes were evident before the onset of clinical
symptoms [104]. Mai et al demonstrated the faecal microbiota of preterm infants was more
heterogeneous one week before NEC diagnosis, with a low carriage of Proteobacteria. In
contrast, blooms of Proteobacteria, a major phylum including the Enterobacteriaceae (Gammap‐
roteobacteria), and a decrease in Firmicutes subsequently occurred preceding the onset of NEC
by at least 72 hours [105]. Other community studies have contrasted the enteric microbiota in
infants without NEC with that of NEC infants at the time of presentation. Smith et al analysed
tissue samples from infants with fulminant NEC undergoing surgery. Using FISH, commun‐
ities of bacteria in the excised tissue samples were investigated. Proteobacteria were present in
most samples, in this instance dominated by E. coli and to a lesser extent by Enterobacter. Overall
composition varied from infant to infant, with some infants showing a high diversity in
bacterial species and others a low diversity. Clostridia, present in a few of the neonatal samples,
were associated with pneumatosis intestinalis diagnosed histologically but this was consid‐
ered to be a secondary effect. The study noted the presence of two more unusual bacteria,
Ralstonia and Propionibacterium, in most samples. However, their ubiquitous nature and lack
of dominance in the tissues suggests they were not the primary pathogens [106]. Wang et al
profiled microbial communities in faecal samples from of 10 NEC infants and 10 non-NEC
controls collected at the time of diagnosis. Limited microbial diversity was seen in all the
preterm infants with a predominance of Gammaproteobacteria. Each infant had a unique
microbiota (including twins) and no specific pathogen was implicated. However, differences
between NEC and control infants were seen. Microbial community structure in the NEC infants
was the least diverse but with a Proteobacteria bloom, which was absent in controls, even though
the same bacterial species were present. NEC infants had received significantly more antibiotic
treatments and it was hypothesised that antibiotics inhibit the bacteria which normally check
the growth of Proteobacteria [107]. These findings are disputed by Mai et al, who found that
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overall microbial diversity at the time of diagnosis does not differ between healthy preterm
infants and those diagnosed with NEC [105].
A confounding factor is that antibiotic therapy is frequently applied to preterm infants with
the possible outcome that the reduced microbial diversity reported to be a feature of NEC
could be a consequence of the antibiotic. Tanaka et al demonstrated antibiotic exposure in the
pre- or early postnatal period greatly influences the enteric microbiota with arrested growth
of beneficial bifidobacteria and overgrowth of Enterococcus and higher Enterobacteriaceae
populations at one month of age [108]. Antibiotic use following preterm rupture of membranes
(PROM) may alter the bacterial flora, and the effect of different antibiotic regimens in PROM
has been examined with regard to the later occurrence of NEC. The Cochrane review by
Kenyon et al found that only beta-lactam antibiotics (including Augmentin) showed an
association with later NEC. The relative risk was 4.72 (1.57 – 14.23) compared to placebo, n =
1880. The duration of initial antibiotic treatment in the NICU has also been shown to affect the
later occurrence of NEC in extremely low birth-weight (ELBW) infants [109]. Cotten et al used
data from 5693 ELBW infants from multiple NICU services to examine the later NEC rate
following initial empiric antibiotic use where the cultures proved negative. There were many
other risk factors for NEC, some of which were also associated with the duration of antibiotic
use, but multivariate analysis allowing for these factors demonstrated that duration of
antibiotic use beyond 5 days was associated with an increased risk of NEC [110].
2.3. Significant microorganisms
Despite many attempts, the specific pathogen theory of NEC has not been proven. The
strongest candidate organisms, commensal members of the Enterobacteriaceae, staphylococci
and clostridia are not universally present in NEC infants and may be found in the enteric
microbiota of infants without NEC. Clostridia are likely to be secondary invaders rather than
primary pathogens. Molecular studies have not uncovered a previously unknown specific
pathogen, although uncultured bacteria have been detected in stools of NEC infants [105,111].
The four criteria known as Koch’s postulates, designed to establish causality between microbes
and disease, are not fulfilled by the existing knowledge of NEC. Gupta et al, who undertook
the first comprehensive case/control study of possible microbial causes, were the first to
establish this fact [58]. Epidemics of classical enteric pathogens, including diarrhoeagenic E.
coli, have been associated with NEC from time to time but most cases appear to be associated
with normal members of the gut microbiota. Mycoplasma hominis and Ureaplasma urealyticum
are associated with preterm birth but appear not to colonise the human gastrointestinal tract.
Using PCR-DGGE, Millar et al were unable to detect these organisms in preterm infants with
or without NEC [111]. The claim that enteric viruses cause NEC has not been substantiated
although it seems likely that they represent a risk factor. The question of whether NEC infants
are colonised by more virulent strains of the same species colonising infants without NEC has
not been fully investigated but, as yet, there is little evidence to support such a hypothesis.
The abnormal colonisation theory, with its emphasis on community structure rather than
specific  organisms,  has  emerged as  the most  likely explanation for  NEC.  Possibly some
members of the microbiota contribute to health while others increase the likelihood of NEC,
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with quantitative changes heralding the onset. Even though they have never been proven to
be the causative agents, Enterobacteriaceae are commonly found in the gut of infants with NEC
and have been isolated from various sites in the body of affected infants [112]. The idea that
a bloom of Proteobacteria  precedes NEC is compatible with existing knowledge and high‐
lights the importance of the Gram-negative Enterobacteriaceae. However, this probably does
not occur in all cases. For example, Smith et al found Gram-positive bacteria dominated the
faecal microbiota of NEC infants whereas a mixed microbiota of Gram-positive and Gram-
negative  bacteria  occurred in  the  control  infants  [113].  Further  investigation of  CoNS is
required, as these are a common component of the enteric microbiota in preterm infants and
have been implicated in NEC. There is no convincing evidence that intestinal colonisation
with enterococci is detrimental to the health of preterm infants. Rather, it may be benefi‐
cial, as some strains of Enterococcus faecalis have been shown to down-regulate the inflamma‐
tory  response,  modulate  innate  immune  function  in  intestinal  cell  lines  and  to  have  a
protective role in bacterial  translocation [85,86,114,115].  In addition to the dominance of
certain  types  of  bacteria,  NEC aetiology may involve  the  absence  of  other  bacteria.  For
example, Blakey et al noted anaerobic Bacteroides spp. and lactobacilli were significantly less
common in NEC infants compared to controls [55]. The paucity of probiotic bacteria in NEC
infants and the phenomenon of microbial interference, where one species of bacteria inhibits
another, are discussed elsewhere.
Several studies challenge the long held belief that the foetus is normally devoid of microor‐
ganisms and it now seems likely that colonisation begins before birth and can be detrimental.
Intrauterine infection is a major cause of prematurity and is associated with adverse neonatal
outcomes [116,117]. According to Gonçalves et al, microorganisms gain access to the amniotic
cavity and foetus by four main pathways: (1) ascending from the vagina and cervix; (2)
transplacental infection; (3) seeding from the peritoneal cavity via the fallopian tubes; (4)
accidental introduction during invasive procedures [118]. The ascending pathway is probably
the most common route of infection and a variety of microorganisms have been implicated
[118]. PCR-based studies, such as that of DiGiulio et al, indicate microbial invasion of the
amniotic cavity is common in the setting of preterm, pre-labour rupture of membranes and is
underestimated using standard culture techniques [119]. Mycoplasma and Ureaplasma are the
predominant genera in the amniotic cavity whereas NEC associated species are less frequently
present [118,119]. Usually clinically silent in the mother, infection of the chorion and amnion
are chronic, proinflammatory events believed to have wide-ranging, deleterious effects on the
foetus [120]. Several investigations have reported an association between chorioamnionitis and
NEC [116, 121–123], although others have failed to show any link [124,125]. A recent meta-
analysis of 33 relevant studies revealed a significant association between clinical chorioam‐
nionitis and NEC but there was no association where histological changes alone were the
indicator of infection. A threefold increased risk of NEC was seen where chorioamnionitis
diagnosed histologically was accompanied by foetal involvement [126]. Additional markers
of inflammation, such as umbilical cord polymorphonuclear cell infiltration, Ureaplasma
urealyticum colonisation and increased cord blood cytokine levels (IL-6, IL-8) have been linked
to NEC. However, other studies have been unable to confirm these findings [126].
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The mechanisms underlying the relationship between intrauterine infection, the inflammatory
pathway and NEC have not been elucidated but animal experimentation indicates intra-
amniotic exposure to lipopolysaccharide or Ureaplasma induces intestinal inflammation in the
foetus resulting in mucosal damage and impaired development of the intestine [127,128]. How
closely these findings mirror the human situation remains to be seen. A contrary argument is
that the foetal inflammatory response may be protective for neonates because it is already
primed to deal with microorganisms interacting with the gut epithelium through the ingestion
of microorganisms in amniotic fluid. Histologic chorioamnionitis is not necessarily associated
with adverse long-term outcomes and may be protective for late onset sepsis [129,130]. On the
other hand, if foetal inflammation is sufficiently damaging, it may predispose the neonate to
NEC through impairment of the epithelial barrier. As noted earlier, despite the importance of
intrauterine Ureaplasma and Mycoplasma as a risk factor for NEC, these microorganisms seem
not to colonise the intestinal tract [111]. Other bacteria, mainly E. faecalis, S. epidermidis and E.
coli, were the predominant species isolated from the meconium of healthy neonates by Jiménez
et al who noted that bacteria can be detected in umbilical cord blood, amniotic fluid and foetal
membranes in the absence of infection and inflammation [131]. Whether these antenatal
gastrointestinal colonisers have a specific role in NEC has not been explored. That NEC occurs
some days after birth suggests either additional microorganisms are required or the existing
microorganisms need time to multiply in order to reach significant numbers.
2.4. Crossing the epithelial barrier
Structure and function
As previously mentioned, motility patterns in the small bowel are poorly developed in the
preterm infant,  particularly before 28 weeks gestation, with gastrointestinal transit  times
ranging from 8-96 hours compared to 4-12 hours in adults [132]. Gastric acid production and
enterokinase  levels  are  low in  the  premature  infant,  which may limit  lipid  and protein
digestion  in  the  small  intestine,  and  together  with  lowered  intestinal  motility  may  be
responsible for bacteria having substrate available for growth for longer periods. In 1990,
Carrion and Egan investigated supplementing the feeds of premature infants with hydro‐
chloric acid. The results were promising, but this approach has not been widely adopted, and
appears not to have been investigated further [133]. It is postulated that bacterial fermenta‐
tion of substrate (lactose) present in the infant gut damages the mucosa through the produc‐
tion of gas, which increases intraluminal pressure. The ability of some commensal species to
ferment lactose is well known but there seems to be no correlation with NEC [58]. The surface
of the gastrointestinal tract must allow entry of molecules that are beneficial to the host while
at the same time preventing harmful microbes from crossing the barrier. Piena-Spoel et al
observed increased intestinal permeability in human neonates with severe NEC, compared
with control babies [134].
The intestinal epithelium from the stomach to the rectum is comprised of a single layer of
polarised epithelial cells. The main functions of these cells are to absorb nutrients and also
to  prevent  luminal  bacteria  and  other  antigens  from crossing  the  intestinal  barrier  and
entering the bloodstream [88]. Extrinsic barriers including gastric acidity, intestinal peristal‐
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sis and the mucus layer limit the access and adhesion of bacteria to the epithelial surface. The
mucus layer  is  an organised extracellular  matrix  containing inorganic  salts,  non-specific
antimicrobials and specific antimicrobial immunoglobulins, water and large glycoproteins
(mucins)  [135].  Mucins  are  produced  by  goblet  cells  within  the  crypts  of  the  intestinal
epithelium and released either constitutively or in response to infecting organisms [135].
Intrinsic barriers, which include the selectively permeable epithelial cell plasma membrane
and the tight junctions that seal the intracellular spaces, block translocation of bacteria and
restrict diffusion of macromolecules. Both these barriers are underdeveloped in the prema‐
ture infant and this coupled with immaturity of the immune or cellular defense mecha‐
nisms may result in bacterial translocation leading to the inflammatory cascade resulting in
NEC, even without prior injury of the mucosa. This hypothesis is supported by the fact that
mice deficient in Muc2 have been shown both to be susceptible to infection and to develop
intestinal inflammation. These mice, as well as having a deficiency in mucus production, had
increased leakiness in the gut, which allowed microbes (both commensals and pathogens) to
transit the mucosa [136]. Bergstrom et al suggest that the epithelium may be subsequently
damaged either as a result of bacteria producing high concentrations of toxic metabolites or,
alternatively,  the  presence  of  the  bacteria  stimulates  recruitment  of  large  numbers  of
polymorphonucleocytes to the site of infection resulting in epithelial cell death as neutro‐
phils  release  cytotoxic  mediators  to  control  the  infection [136].  The blooms of  intestinal
Proteobacteria seen prior to the onset of NEC in some infants may directly increase their rate
of translocation via non-specific phagocytic uptake by epithelial cells lining the villi. Indige‐
nous Enterobacteriaceae are considered to translocate with the greatest efficiency, S. epidermi‐
dis with moderate efficiency and obligate anaerobes with the least efficiency [137].
Tight Junctions
Tight junctions and adherens junctions are critical for maintenance of gut permeability and
intestinal barrier function [138,139]. Tight junctions form a permeable barrier allowing the
passage of fluids and solutes but not the other contents of the intestinal lumen. These junctions
are made up of trans-membrane proteins (including occludins, claudins) and junctional
adhesion proteins as well as cytoplasmic proteins (zona occludens - ZO-1, ZO-2, ZO-3) [140].
Using an epithelial cell monolayer (Caco2 cells) as in vitro model intestinal barrier, Han et al
were able to demonstrate that proinflammatory cytokines interferon -γ, tumor necrosis factor
- α and interleukin -1β could affect the expression of occludins and claudins involved in
formation of tight junctions [141]. Another study demonstrated that epidermal growth factor
prevented the disruption of tight junction proteins in an injury model using Caco-2 monolayers
[142]. The importance of occludins and claudins in the formation of functional tight junctions
has also been demonstrated in animal models of NEC where a positive correlation between
ileal occludin mRNA levels and the progression of ileal injury was noted [143]. Erythropoietin
(Epo), a component of human milk, has been suggested to have a physiological role in the
developing gut. In vitro studies undertaken by Shiou et al, demonstrated that Epo is able to
reverse the effect of IFN - γ and protect ZO-1 expression and barrier function [140]. In a rat
model of NEC the same authors demonstrated that oral administration of Epo was able to
reduce the incidence of NEC from 45% to 23%. If tight junctions are improperly formed or if
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they are damaged as a result of cytokine production in response to bacteria interacting with
intestinal epithelial cells then bacteria will be able to translocate into the tissue causing some
of the typical symptoms observed in NEC e.g. intramural gas. Reduced tight junction com‐
plexes have been associated with chronic inflammation in diseases such as ulcerative colitis
and Crohn’s disease. In these conditions there are often more bacteria found in association
with the epithelium [144].
It is known that signals from the bacteria colonising the gut after birth play a role in maturation
of physiological, anatomical and biochemical functions of the intestinal epithelial barrier [145].
Comparisons between conventional and gnotobiotic animals have demonstrated that the
microbiota is involved in development, maintenance and repair of the intestinal mucosa
[139,145]. As outlined previously, colonisation of the gut in neonates is influenced by gestation,
postnatal age, environmental factors such as diet and the rearing environment, and adminis‐
tration of antibiotics. Cilieborg et al conclude that genetically determined gut characteristics
(structure, function, immunity) and the time and mode of birth are the most crucial factors in
the development of the enteric microbiota, which may be of a beneficial or harmful nature in
terms of mucosal integrity [146]. C. sakazakii provides a good example of a potentially harmful
member of the microbiota in that it is believed to trigger intestinal disease by modulating
enterocyte-signalling pathways resulting in cell apoptosis [112]. This pathogen is also notable
for its ability to induce the disruption of the tight junctions between enterocytes [147].
Mechanisms
The mechanisms by which classical enteric pathogens cross the intestinal epithelial barrier
have been carefully studied as they provide putative targets for the prevention and treat‐
ment of infectious diarrhoeal diseases. Adherence is generally the beginning of the colonisa‐
tion process leading to infection and, for invasive pathogens such as Salmonella and the NEC
pathogen  C.  sakazakii,  adherence  is  a  prerequisite  to  internalisation  in  enterocytes.  It  is
generally assumed that NEC-associated bacteria adhere to enterocytes prior to the develop‐
ment of the disease [148,149]. While direct evidence is lacking, animal studies support this
contention and, from a theoretical point of view, it could be an essential step [85]. Adher‐
ence prevents bacteria being removed by luminal flow allowing them to deliver cytotoxic
molecules,  endotoxin  and other  pro-inflammatory  substances  directly  to  the  epithelium.
Features  of  the  preterm  intestine  previously  discussed  such  as  scanty  mucous,  lack  of
secretory IgA and delayed colonisation with inhibitory probiotic bacteria certainly provide
an opportunity for adherence of commensals to occur. When tested in an in vitro system, we
found Enterobacteriaceae isolated from stool samples of NEC infants could adhere to both large
(HT29) and small (CaCo-2) intestinal cell lines, although most did not adhere to the same
extent as the diarrhoeagenic E. coli O111 control [69,150]. Such adherent bacteria may act as
anchors for the formation of microcolonies on the mucosal surface, facilitating translocation
through interactions with the innate immune system.
There is potential for bacterial cytotoxins to assist translocation of bacteria in the gut lumen
through induction of enterocyte death. In a pilot study, we investigated 53 Enterobacteriaceae
colonies cultured from the stools of four infants with NEC (at time of diagnosis) and four
infants without NEC for cytotoxin production. The criteria for NEC diagnosis and selection of
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NEC –ve infants were as specified by Brooks et al [69]. Cell-free, broth culture supernatants
prepared from multiple bacterial colonies per stool sample were tested against a large bowel
tissue culture cell line, HT29, as previously described [151]. Cytotoxic supernatants were
diluted two-fold and re-tested to obtain the titre. All colonies were identified using API 20E
biochemical test strips (bioMérieux). A small minority of the supernatants showed cytotoxic
activity (Table 3), but there was no significant difference in their occurrence in NEC versus
non-NEC infants or in the amount of toxin produced. Toxin producers were identified as
Serratia marcescens (both groups), Klebsiella oxytoca (NEC positive group), Escherichia vulneris
and Klebsiella pneumoniae ss. pneumoniae (NEC negative group). Serratia marcescens is known to
produce pore-forming toxins, which may explain its cytotoxic activity for HT29 cells [152].
Cytotoxic activity in Escherichia vulneris and Klebsiella pneumoniae ss. pneumoniae is not recorded
elsewhere. However, cytotoxin production in some strains of Klebsiella oxytoca has recently
been described [153].
Infants NEC positive (n=4) NEC negative (n=4)
Cytotoxin Positive Negative Positive Negative
Number of isolates 3 30 4 16
Toxin titre range 4–16 8–16
Table 3. Cytotoxin production in Enterobacteriaceae from stool samples of infants with and without necrotising
enterocolitis
3. Maturity of the gut and the innate immune response
As described in the previous section, the extrinsic barriers in the premature gut are not fully
developed. Goblet cells, found throughout the intestine, are responsible for the secretion of
mucus that protects the intestinal lining as well as providing some protections and nutrients
for the bacteria that colonise it. There are both secretory mucins (Muc2) and membrane bound
mucins (Muc3), which are co-secreted with trefoil factors (TFFs) [139]. The intestine can
respond to injury by increasing mucin production. Resident microbes in the gut can also induce
an increase in mucin production [154]. Mucins have been implicated in cellular signalling by
virtue of the fact that they are able to develop binding sites for lectins, adhesion molecules,
cytokines and chemokines. In the immature gut the coverage of mucin is scanty which may
facilitate bacterial adherence to the epithelial cells. Paneth cells in the small intestine are able
to secrete a wide spectrum of antimicrobial peptides against bacteria, fungi and viruses.
Microfold (M) cells in the intestine sample the intestinal environment and deliver antigens to
more specialised lymphoid tissue. Their role in disease in the premature neonate is unknown.
However, impaired production of both MUC2 and TFF3 has been reported in clinical and
experimental cases of NEC [139]. In a rat model of NEC Khailova et al demonstrated that when
rats were given a probiotic bacterial strain Bifidobacterium bifidum that regulation of the mucin
layer was observed with levels of mucin3 and TFF3 similar to those of control animals [139].
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The innate immune system of the intestinal epithelium barrier has to be able to distinguish
commensal bacteria from pathogens. Pattern recognition receptors on the intestinal epithelial
barrier (transmembrane Toll-like receptors and intracellular nucleotide binding oligomerisa‐
tion domain –like (NOD) receptors) have to be able to recognise microbial ligands (lipopoly‐
saccharide, flagellin, lipotechoic acid, peptidoglycans and formylated peptides) known as
microbial-associated molecular patterns (MAMPs). Depending on how the signal is perceived
a number of responses can be generated - with commensal bacteria a protective response; with
pathogenic bacteria an inflammatory response; or it can be a response that triggers apoptosis
[145]. Commensal bacteria can dampen TLR-mediated inflammatory signals. The nuclear
factor kappa B (NFκB) transcriptional control pathway has both anti-inflammatory and pro-
inflammatory roles dependent on the microbial signal received [145]. Once the MAMP has
bound to its respective TLR, the TLR triggers recruitment of the myeloid differentiation
primary-response gene 88 (Myd88), which then recruits another protein known as IL-1R
associated protein kinase. Activation of this gene leads to activation of NFκB and other
regulators of gene expression. Along with the expression of inflammatory genes this is the
basis of the innate immune response in the gut [155]. Receptors of the innate immune system
are expressed on intestinal epithelial cells and also antigen presenting cells such as macro‐
phages and dendritic cells. Discrimination of pathogenic bacteria from commensal bacteria is
mediated by the trans membrane TLRs and the intracellular NOD isoforms [155]. The gut
associated lymphoid tissue is made up of Peyers Patches, which can be described as mucosal
lymph nodes overlaid with M cells. M cells have endocytic organelles that facilitate uptake of
antigens from the intestinal lumen. Peyers Patches contain several types of antigen presenting
cells such as dendritic cells and B cells. The lamina propria of the gut contains antigen
presenting T cells, antibody secreting B cells, T cells and macrophages [156].
The microbiota, mucin and antibacterial products such as defensins and immunoglobulins
help protect the host against pathogens. In infants with NEC who have a poorly developed
gut with little mucin production and an abnormal microbiota compared to full term healthy
infants, the potential for bacteria to cross the intestinal barrier and initiate inflammatory
disease is much greater. Once we have a better understanding of the microbial-mucosal
signalling components of inflammatory pathways and the regulation of these by commensal
bacteria we may be able to find new ways of preventing NEC in premature infants. Alterna‐
tively, or as well as, damage to the intestinal mucosa by enteric viruses, harmful members of
the gut microbiota, acidic or toxic luminal contents are likely to facilitate translocation. Injury
due to hypoxic-ischaemic events in late-onset NEC is generally considered to be transient and
unlikely to directly induce translocation. However, there may be subtle effects and when
severe, it could be a permissive factor [20].
4. The inflammatory response
The initial step in any infection is the adherence of a microorganism to a host surface. As
previously discussed, this binding may trigger a number of host responses such as chemokine
and cytokine release, alterations in intracellular signalling pathways and induction of apop‐
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tosis. Cytokines play an important role in the regulation of inflammation. In cases of NEC
several cytokines have been identified as being associated with the disease. A number of pro-
inflammatory cytokines (IL-1β, IL-6, IL-12, IL-18 and TNF-α), an anti-inflammatory cytokine
(IL-10) and platelet activating factor (PAF) have been associated with NEC pathogenesis and
neonatal sepsis in both infants and in animal models of NEC [157–159].
Pro-inflammatory cytokines can cause increased production of nitric oxide which is known to
modulate various physiological processes including inflammation [88,141,]. Nitric oxide is
produced from arginine by nitric oxide synthases of which there are three isoforms one of
which is inducible (iNOS). This inducible isoform is expressed at high levels during inflam‐
mation and is activated by cytokines such as gamma interferon and by bacterial lipopolysac‐
charide [88,160]. Nitric oxide may cause damage either directly or through its toxic
intermediate, ONOO- resulting in a direct cytopathic effect on the cells (apoptosis) and
inhibiting enterocyte proliferation and migration so that the intestinal mucosa cannot repair
itself [88]. iNOS knockout mice have been shown to be more susceptible to infection with a
number of microorganisms including Porphyomonas gingivalis and Salmonella [160]. Intestinal
iNOS expression increased in the terminal ileum in a rat model of NEC with concurrent
enterocyte apoptosis and decreased IL-12 production [161]. IL-12 is involved in bacterial
clearance. Surgical specimens from infants with acute NEC have also demonstrated increased
levels of iNOS and gamma interferon mRNA [157].
Platelet activating factor (PAF) has also been implicated in cases of NEC. This pro-inflamma‐
tory lipid mediator has been associated with intestinal mucosal injury and bowel necrosis in
animal models of NEC and neonates with NEC [162,163]. A two-step enzymatic process is used
to produce PAF [163]. Experimental animal model research has suggested that both PAF and
intestinal bacteria are required to cause NEC as PAF alone cannot induce experimental NEC
in a rodent model in the absence of the intestinal microflora [164,165]. PAF is released in
response to hypoxia, infection or local injury and Soliman et al hypothesise that this then results
in up-regulation of TLR4 in the intestinal epithelium allowing excessive bacterial activation of
the intestinal inflammatory response [163]. Another group has also demonstrated that when
PAF degrading enzyme is given in association with enteral feeding in a rat model of NEC that
initiation of NEC is prevented [166].
IL-10 plays a protective role in the pathogenesis of NEC. Using wild type and IL-10 knockout
mice Emami et al have demonstrated that in IL-10 deficient mice there is more evidence of
epithelial apoptosis and dissociation of tight junctions compared to wild type animals [159].
In addition, when IL-10 knockout mouse pups were treated with IL-10 or phosphate buffered
saline, pups given IL-10 had a greater rate of survival than the PBS treated pups and improved
intestinal villus architecture. IL-10 can suppress the secretion of pro-inflammatory cytokines
such as IL-2, TNF-α and gamma interferon. This cytokine is found in human breast milk and
has been postulated to be one of the protective factors preventing the development of NEC.
In addition, IL-10 can suppress expression of iNOS at the mucosal level in macrophages [167].
As described above, high levels of iNOS have been associated with cases of NEC. Lee and Chau
have demonstrated that the enzyme heme-oxygenase -1 is induced by IL-10 and that this
enzyme is required to mediate the action of IL-10 both in vitro and in vivo. When an HO
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inhibitor was given to mice, IL-10 mediated protection against LPS-induced septic shock was
decreased [167]. IL-10 protection appears to be the result of down regulation of iNOS expres‐
sion leading to less damage of the intestinal surface. However, if levels of HO-1 are reduced
or absent IL-10 is not able to control iNOS expression. Further evidence for the role of NO in
NEC has been provided by Ford et al who examined levels of inflammatory cytokines and NO
in samples of intestine obtained from infants undergoing surgical resection for NEC and who
demonstrated that NO was produced in large amounts by enterocytes in the intestinal wall
leading to apoptosis of enterocytes in apical villi through peroxynitrite formation [157].
4.1. Signaling pathways
One of the newer approaches to understanding the pathology of NEC has been at a molecular
level and examines the relationship between the intestinal epithelium and commensal bacteria.
This research has identified a class of bacterial receptors known as Toll-like receptors (TLRs),
in particular TLR 4, whose ability to respond to bacteria associated with the intestinal epithe‐
lium may in part explain why some premature infants are susceptible to NEC. More than ten
TLRs have so far been identified in humans [168]. These receptors form part of the innate
immune response and interact with different components of bacteria and viruses. TLR4, for
example, is known to be the receptor for bacterial lipopolysaccharide. As NEC has often been
shown to develop after gut colonisation with Gram-negative strains of bacteria, a putative role
for TLR4 in the pathogenesis of this disease has been suggested. Mice with mutations in TLR4
or lacking TLR4 do not develop NEC [24,165]. Activation of enterocyte TLR4 leads to increased
death of cells in the intestine through the mechanism of apoptosis [169]. TLR4 activation results
in stimulation of IL-1R kinase via adaptor molecules MyD88 and MD2 resulting in activation
through NFκB and up-regulation of pro-inflammatory cytokines [24]. Gribar et al have
demonstrated that TLR4 expression is higher during gestation in the mouse and falls off shortly
before birth [170]. They have also postulated a link between TLR4 levels and TLR9 levels in
the pathogenesis of NEC. TLR9 recognises bacterial DNA as opposed to LPS recognised by
TLR4. TLR4 levels are increased in the bowel of infants with NEC compared to control bowel
samples [24]. In a mouse model of NEC, Leaphart et al demonstrated that physiological
stressors such as hypoxia and LPS associated with the development of NEC sensitise the
epithelium to LPS through the up-regulation of TLR4 and that if animals had a mutation in
TLR4 the severity of NEC was reduced due to increased healing capacity of the epithelium [24].
Thus the effect of TLR4 appears to be two-fold by promoting damage to the small intestine
through up-regulation of inflammatory cytokines and in reducing mucosal repair. As reported
in the last section, there is also a known relationship between TLR4 up-regulation and PAF,
one of the molecules implicated in the pathogenesis of NEC.
The relationship between TLR4 and TLR 9 and the signalling from both these receptors has an
important role to play in the development of NEC [170]. In cases of NEC, in both humans and
mice, increased TLR4 and decreased TLR9 expression was measured. TLR9 recognises CpG
motifs of bacterial DNA. Bacterial DNA differs from human DNA in that is enriched with CpG
motifs and is largely unmethylated [170]. Using a murine model of NEC, Gibrar et al demon‐
strated that NEC occurs when there is increased TLR4 and decreased TLR9 expression in
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developing intestinal mucosa. Furthermore, they were able to show that activation of TLR9
with CpG-DNA inhibited TLR4 mediated signalling in enterocytes. The mechanism of
inhibition was dependent upon the inhibitory signalling molecule IL-1R kinase. When CpG-
DNA was administered to newborn mice the incidence of experimental NEC was significantly
reduced. Other studies have also implicated TLR2 in the pathogenesis of NEC. TLR2 mRNA
expression was increased along with TLR4 mRNA and activated NFκB in a neonatal rat model
of NEC 48 hours prior to lesions being identified histologically [171,172]. TLR2 mediates host
response to Gram-positive bacteria and yeasts through the NFκB pathway [173].
Figure 1. Effects of microbial stimulation on cellular outputs. Toll-like receptors (TLR) and nucleotide-binding oligo‐
merisation domain-like (NOD) receptors recognise patterns of bacterial signals. The outcome of this interaction is vari‐
able depending on the commensal or pathogenic status of the bacteria.
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Signalling pathways of the innate immune system therefore play an important role in the
development of NEC. Understanding of the interactions in this system may lead to the
development of new therapeutic treatments for NEC e.g. probiotics with known effects on
signalling pathways, anti-inflammatory molecules.
4.2. Cell damage
When pieces of bowel are removed during surgery for NEC and examined histologically, a
large number of apoptotic nuclei signifying programmed cell death are observed in the tissues
[157]. Studies using an animal model of NEC have demonstrated that apoptosis occurs prior
to gross histological damage. When apoptosis was prevented using caspase inhibitors, the
development of NEC was significantly reduced [174]. Also, the neonatal pathogen C. sakaza‐
kii is known to induce apoptosis in enterocytes. As the predominant anatomic lesion of NEC
is coagulative or ischaemic necrosis, the contribution of apoptosis requires some explanation
[2]. Necrosis is a term currently used by cell biologists for non-apoptotic, accidental cell death
and by pathologists to denote the presence of dead tissue or cells regardless of how they have
died. In the absence of efficient phagocytosis, apoptotic bodies may lose their integrity and
proceed to secondary or apoptotic necrosis. Thus the presence of necrosis indicates cell death
has occurred, but does not necessarily indicate how [175].
5. Hypothetical model of NEC
NEC is a complex disease influenced by several risk factors that may act alone and together.
The innate immune system appears to play a large role in the establishment of NEC. We
propose that in the preterm infant susceptible to NEC, scanty mucus production allows
interaction between commensal bacteria and TLR triggering the innate immune response
leading to loosening of intercellular tight junctions, enterocyte apoptosis and necrosis,
resulting in translocation of bacteria (Figure 2a). Additional factors may also increase trans‐
location, including infection with enteric viruses, presence of microbial cytotoxins or other
toxic substances, and a bloom of certain bacteria in the gut lumen causing increased phagocytic
uptake by enterocytes. In comparison, the intestinal epithelium of the healthy term neonate
secretes adequate mucus, trapping enteric bacteria in the upper layers. In addition, the
presence of sIgA and other antimicrobial substance inhibit bacterial colonisation of entero‐
cytes, and any commensal bacteria that do adhere are recognised as not harmful, dampening
TLR-mediated inflammatory signals (Figure 2b). In essence, a pivotal event in the development
of NEC may be whether the innate immune system of the preterm infant intestine views
bacteria reaching the enterocyte surface as friend or foe.
6. Probiotics
Microbial succession ensures that the intestines of healthy neonates are readily colonised with
probiotic bacteria such as Bifidobacterium and Lactobacillus. In contrast, colonisation with these
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bacteria is delayed in preterm infants [6]. Probiotic bacteria are avirulent, generally of human
origin, and purported to have a number of beneficial effects. They are used both prophylacti‐
cally and as a treatment for certain infections but claims they can colonise the bowel are more
controversial, probably because this depends on the specific probiotic. Enteric probiotics may
reduce the incidence and severity of diarrhoea due to enteric pathogens through competitive
inhibition and/or production of antimicrobial substances. They have been shown to attenuate
nitric oxide production, increase antioxidant activities, improve the mucosal barrier, upregu‐
late anti-inflammatory and downregulate pro-inflammatory responses [6-8,176]. Additional
probiotic effects, such as regulation of apoptosis and prevention of intestinal injury by C.
sakazakii have been demonstrated in animal models of NEC [6]. All of these effects are relevant
to the prevention of NEC and suggest that probiotics are the ideal, low-cost intervention for
preterm and low birth-weight infants. The main difficulty in assessing the efficacy of probiotics
for the prevention of NEC is that different bacterial species or strains with different probiotic
effects are used in each study, so that the optimum probiotic for NEC, and the biological
characteristics that it should possess, have not been well defined.
Trials of probiotics in preterm infants have had varying results. Those reporting a reduction
in NEC have often employed Bifidobacterium, a dominant genus in the intestines of healthy
infants, with or without other probiotic genera [177]. Efficacy in a rat model of NEC has also
been demonstrated [139]. Administration of Bifidobacterium together with Lactobacillus is
known to promote the growth of indigenous lactic acid bacteria through the production of
short-chain fatty acids [178]. Administration of Lactobacillus alone does not appear to prevent
NEC and Deshpande et al caution against its use [179]. In the NICU at Dunedin Hospital,
Infloran, a probiotic mix of Bifidobacterium infantis and Lactobacillus acidophilus, is prescribed
for infants <1500 g. It has performed well in trials, reducing the incidence of NEC by more than
50% [8]. A recent meta-analysis demonstrated that prophylactic probiotic therapy reduced the
incidence of NEC by 30% overall, confirming the significant benefits of supplementation [179].
The risk that in critically ill neonates, or those with compromised gut integrity, probiotics may
translocate into the bloodstream has been considered and this is an area requiring further
investigation [178,180]. Nevertheless, probiotics are regarded as a promising approach for the
prevention of neonatal NEC [7,8].
Cario et al demonstrated that TLR -2 was able to control mucosal inflammation in both in vivo
and in vitro models by preserving TJ associated barrier assembly against stress-induced
damage via MyD88. When colitis was induced in wild type mice using dextran sodium
sulphate followed by treatment with a TLR-2 agonist, clinical signs of colitis were abrogated
in all animals when compared to mice which didn’t undergo treatment [181]. The probiotic
Bifidobactrium bifidum was shown to up-regulate expression of TLR-2 in the ileum in a rat model
of NEC and this was associated with significantly reduced epithelial apoptosis [139].
Whether probiotic therapy in preterm infants should include supplementation with prebiotics
is open to question. Prebiotics promoting the growth of bifidobacteria and lactobacilli are
naturally present as oligosaccharides in human milk [8]. The few existing trials of prebiotics
in preterm infant have indicated an increase in stool counts of bifidobacteria and lactobacilli
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occurs. However, until more data is available, routine feed supplementation with prebiotics
or synbiotics (probiotic, prebiotic mixtures) is not recommended [6].
 
(b) 
(a) 
Figure 2. a) Progression of events leading to necrotising enterocolitis in the preterm infant. A bloom of bacteria due
to low intestinal motility increases phagocytic uptake. Scanty mucus and reduced antimicrobial factors allow bacteria
to adhere to enterocytes, activating NFKB via TRL leading to enterocyte apoptosis, necrosis and loosening of tight
junctions. Bacterial translocation may be increased by presence of enteric viruses or microbial and other toxins. b) In‐
testinal epithelium of the healthy, term neonate. Diversity of enteric microbiota and normal gut motility prevent a
bloom of one type of bacteria. Thick mucus, sIgA and other antimicrobial factors inhibit bacterial adherence.
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7. Future directions
An article rather pessimistically entitled ‘Necrotizing enterocolitis – 150 years of fruitless
search for the cause’ was published in 2011 [14]. We believe the search has been fruitful
and a fuller picture of NEC is now beginning to emerge. NEC is a far more complex disease
than early researchers anticipated,  involving intrinsic gastrointestinal  barriers,  the innate
immune response, signalling pathways and bacterial colonisation patterns. It seems likely
that  in  individual  cases  of  NEC  there  will  be  differences  in  both  the  aetiology  and
pathogenesis.  Research  into  this  disease  will  always  be  hampered  by  the  fragility  and
vulnerability of the patients and ethical considerations, leading to a greater dependence on
in vitro and animal model experimentation than is usual.  Although necessary, antibiotic
therapy  is  often  a  confounding  factor  in  NEC  research  because  it  may  eliminate  the
microbes that initiated the infection. Prospective studies represent a promising avenue of
research especially when combined with DNA or RNA based methods for studying changes
in  the  enteric  microbiota,  initiation  of  the  inflammatory  pathway  and  cell  signalling.
Through  increasing  our  understanding  of  NEC,  new  targets  for  intervention  will  be
identified.  Further  investigation  of  the  mechanisms  of  action  of  probiotic  bacteria  will
hopefully identify the ideal probiotic for NEC prevention. There is every reason not to be
pessimistic  about  our  ability  to  treat,  and more  importantly  to  prevent,  this  potentially
devastating disease of preterm infants in the future.
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